Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody Therapy.
Journal
medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986
Informations de publication
Date de publication:
15 Sep 2021
15 Sep 2021
Historique:
entrez:
21
9
2021
pubmed:
22
9
2021
medline:
22
9
2021
Statut:
epublish
Résumé
Resistance mutations to monoclonal antibody (mAb) therapy has been reported, but in the non-immunosuppressed population, it is unclear if
Identifiants
pubmed: 34545376
doi: 10.1101/2021.09.03.21263105
pmc: PMC8452115
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NIH HHS
ID : R01 OD011095
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002548
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI028433
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069463
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068636
Pays : United States